North America Non-invasive Aesthetic Treatment Market Size, Share & Industry Trends Analysis Report By End-Use (MedSpa, Hospital/Surgery Center, Traditional Spa, and HCP Owned Clinic), By Procedure, By Country and Growth Forecast, 2021 - 2027
Description
North America Non-invasive Aesthetic Treatment Market Size, Share & Industry Trends Analysis Report By End-Use (MedSpa, Hospital/Surgery Center, Traditional Spa, and HCP Owned Clinic), By Procedure, By Country and Growth Forecast, 2021 - 2027
The North America Non-invasive Aesthetic Treatment Market would witness market growth of 13.2% CAGR during the forecast period (2021-2027).
The non-invasive aesthetic treatments are being increasingly opted by a large number of beauty conscious people across the world Some of the non-invasive aesthetic treatments such as hydrafacial use a combination of methods to rejuvenate the skin. This procedure integrates hydration, extraction, exfoliating & cleansing to provide with an effective facial treatment. Additionally, the procedures like belotero lips claims to result in plump lips by the use of injections & injective fillers.
The non-invasive treatment such as microneedling enables the client to get the radiant complexion. Ultherapy is a non-invasive treatment decreasing for skin tightening. The device for this treatment uses micro focused ultrasound energy which creates a heated effect under the skin resulting in natural collagen & elastin production.
Moreover, the non-invasive aesthetic treatments are cost effective. These treatments do not require surgeries and involve minimal to no pain which eliminates the need of anesthesia. The client is not required to spend extra money for hospital stays. Also, they can easily continue with their jobs which eliminate the need of medical leaves for long time resulting in deduction to their salaries.
The preference of people in the North America region has shifted towards the non-invasive aesthetic treatments. A large number of Canadians are choosing injectables for the reduction of wrinkles. The government initiatives also play a crucial role in high adoption of non-invasive aesthetic treatments in the Canadian market. Health Canada has made it mandatory for the providers of cosmetic injectables to provide the report of possible reactions of the products they are marketing.
Additionally, the department has also provided the facility to report any kind of adverse reactions through mails, fax, and telephone or at MedEffect Canada website. Also, the adverse reactions can be reported at the toll free number of Health Products and Food Branch Inspectorate provided by the department.
The US market dominated the North America Non-invasive Aesthetic Treatment Market by Country 2020, and would continue to be a dominant market till 2027; thereby, achieving a market value of $30.5 billion by 2027. The Canada market is exhibiting CAGR of 15.8% during (2021 - 2027). Additionally, The Mexico market would witness a CAGR of 14.8% during (2021 - 2027).
Based on End-Use, the market is segmented into MedSpa, Hospital/Surgery Center, Traditional Spa, and HCP Owned Clinic. Based on Procedure, the market is segmented into Injectables, Skin Rejuvenation, and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Alma Lasers Ltd., Allergan PLC, Galderma S.A., Merz Pharma GmbH & Co. KGaA, Johnson & Johnson, Candela Medical Corporation, Bausch Health Companies, Inc., Cutera, Inc., Lumenis Ltd., and Hologic, Inc.
Scope of the Study
Market Segments covered in the Report:
By End-use
The North America Non-invasive Aesthetic Treatment Market would witness market growth of 13.2% CAGR during the forecast period (2021-2027).
The non-invasive aesthetic treatments are being increasingly opted by a large number of beauty conscious people across the world Some of the non-invasive aesthetic treatments such as hydrafacial use a combination of methods to rejuvenate the skin. This procedure integrates hydration, extraction, exfoliating & cleansing to provide with an effective facial treatment. Additionally, the procedures like belotero lips claims to result in plump lips by the use of injections & injective fillers.
The non-invasive treatment such as microneedling enables the client to get the radiant complexion. Ultherapy is a non-invasive treatment decreasing for skin tightening. The device for this treatment uses micro focused ultrasound energy which creates a heated effect under the skin resulting in natural collagen & elastin production.
Moreover, the non-invasive aesthetic treatments are cost effective. These treatments do not require surgeries and involve minimal to no pain which eliminates the need of anesthesia. The client is not required to spend extra money for hospital stays. Also, they can easily continue with their jobs which eliminate the need of medical leaves for long time resulting in deduction to their salaries.
The preference of people in the North America region has shifted towards the non-invasive aesthetic treatments. A large number of Canadians are choosing injectables for the reduction of wrinkles. The government initiatives also play a crucial role in high adoption of non-invasive aesthetic treatments in the Canadian market. Health Canada has made it mandatory for the providers of cosmetic injectables to provide the report of possible reactions of the products they are marketing.
Additionally, the department has also provided the facility to report any kind of adverse reactions through mails, fax, and telephone or at MedEffect Canada website. Also, the adverse reactions can be reported at the toll free number of Health Products and Food Branch Inspectorate provided by the department.
The US market dominated the North America Non-invasive Aesthetic Treatment Market by Country 2020, and would continue to be a dominant market till 2027; thereby, achieving a market value of $30.5 billion by 2027. The Canada market is exhibiting CAGR of 15.8% during (2021 - 2027). Additionally, The Mexico market would witness a CAGR of 14.8% during (2021 - 2027).
Based on End-Use, the market is segmented into MedSpa, Hospital/Surgery Center, Traditional Spa, and HCP Owned Clinic. Based on Procedure, the market is segmented into Injectables, Skin Rejuvenation, and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Alma Lasers Ltd., Allergan PLC, Galderma S.A., Merz Pharma GmbH & Co. KGaA, Johnson & Johnson, Candela Medical Corporation, Bausch Health Companies, Inc., Cutera, Inc., Lumenis Ltd., and Hologic, Inc.
Scope of the Study
Market Segments covered in the Report:
By End-use
- MedSpa
- Hospital/Surgery Center
- Traditional Spa
- HCP Owned Clinic
- Injectables
- Skin Rejuvenation
- Others
- US
- Canada
- Mexico
- Rest of North America
- Alma Lasers Ltd.
- Allergan PLC
- Galderma S.A.
- Merz Pharma GmbH & Co. KGaA
- Johnson & Johnson
- Candela Medical Corporation
- Bausch Health Companies, Inc.
- Cutera, Inc.
- Lumenis Ltd.
- Hologic, Inc.
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
75 Pages
- Chapter 1. Market Scope & Methodology
- 1.1 Market Definition
- 1.2 Objectives
- 1.3 Market Scope
- 1.4 Segmentation
- 1.4.1 North America Non-invasive Aesthetic Treatment Market, by End-use
- 1.4.2 North America Non-invasive Aesthetic Treatment Market, by Procedure
- 1.4.3 North America Non-invasive Aesthetic Treatment Market, by Country
- 1.5 Methodology for the research
- Chapter 2. Market Overview
- 2.1 Introduction
- 2.1.1 Overview
- 2.1.1.1 Market Composition & Scenario
- 2.2 Key Factors Impacting the Market
- 2.2.1 Market Drivers
- 2.2.2 Market Restraints
- Chapter 3. Competition Analysis - Global
- 3.1 KBV Cardinal Matrix
- 3.2 Recent Industry Wide Strategic Developments
- 3.2.1 Product Launches and Product Expansions
- 3.2.2 Acquisition and Mergers
- 3.2.3 Partnerships, Collaborations and Agreements
- 3.2.4 Approvals and Trials
- 3.3 Top Winning Strategies
- 3.3.1 Key Leading Strategies: Percentage Distribution (2017-2021)
- 3.3.2 Key Strategic Move: (Product Launches and Product Expansions: 2017, Sep – 2022, Feb) Leading Players
- Chapter 4. North America Non-invasive Aesthetic Treatment Market by End-use
- 4.1 North America MedSpa Market by Country
- 4.2 North America Hospital/Surgery Center Market by Country
- 4.3 North America Traditional Spa Market by Country
- 4.4 North America HCP Owned Clinic Market by Country
- Chapter 5. North America Non-invasive Aesthetic Treatment Market by Procedure
- 5.1 North America Injectables Market by Country
- 5.2 North America Skin Rejuvenation Market by Country
- 5.3 North America Others Market by Country
- Chapter 6. North America Non-invasive Aesthetic Treatment Market by Country
- 6.1 US Non-invasive Aesthetic Treatment Market
- 6.1.1 US Non-invasive Aesthetic Treatment Market by End-use
- 6.1.2 US Non-invasive Aesthetic Treatment Market by Procedure
- 6.2 Canada Non-invasive Aesthetic Treatment Market
- 6.2.1 Canada Non-invasive Aesthetic Treatment Market by End-use
- 6.2.2 Canada Non-invasive Aesthetic Treatment Market by Procedure
- 6.3 Mexico Non-invasive Aesthetic Treatment Market
- 6.3.1 Mexico Non-invasive Aesthetic Treatment Market by End-use
- 6.3.2 Mexico Non-invasive Aesthetic Treatment Market by Procedure
- 6.4 Rest of North America Non-invasive Aesthetic Treatment Market
- 6.4.1 Rest of North America Non-invasive Aesthetic Treatment Market by End-use
- 6.4.2 Rest of North America Non-invasive Aesthetic Treatment Market by Procedure
- Chapter 7. Company Profiles
- 7.1 Alma Lasers Ltd. (Sisram Medical Ltd.)
- 7.1.1 Company Overview
- 7.1.2 Financial Analysis
- 7.1.3 Segmental and Regional Analysis
- 7.1.4 Research & Development Expense
- 7.1.5 Recent strategies and developments:
- 7.1.5.1 Product Launches and Product Expansions:
- 7.1.5.2 Approvals and Agreements:
- 7.1.5.3 Acquisitions and Mergers:
- 7.1.5.4 Partnerships, Collaborations and Agreements:
- 7.2 Allergan PLC (AbbVie)
- 7.2.1 Company Overview
- 7.2.2 Financial Analysis
- 7.2.3 Regional Analysis
- 7.2.4 Research & Development Expense
- 7.2.5 Recent strategies and developments:
- 7.2.5.1 Acquisitions and Mergers:
- 7.2.5.2 Product Launches and Product Expansions:
- 7.2.5.3 Approvals and Trials:
- 7.3 Galderma S.A.
- 7.3.1 Company Overview
- 7.3.2 Recent strategies and developments:
- 7.3.2.1 Partnerships, Collaborations and Agreements:
- 7.4 Merz Pharma GmbH & Co. KGaA
- 7.4.1 Company Overview
- 7.4.2 Recent strategies and developments:
- 7.4.2.1 Product Launches and Product Expansions:
- 7.5 Johnson & Johnson
- 7.5.1 Company Overview
- 7.5.2 Financial Analysis
- 7.5.3 Segmental &Regional Analysis
- 7.5.4 Research & Development Expenses
- 7.6 Candela Medical Corporation
- 7.6.1 Company Overview
- 7.6.2 Recent strategies and developments:
- 7.6.2.1 Acquisitions and Mergers:
- 7.6.2.2 Partnerships, Collaborations and Agreements:
- 7.7 Bausch Health Companies, Inc.
- 7.7.1 Company Overview
- 7.7.2 Financial Analysis
- 7.7.3 Segmental and Regional Analysis
- 7.7.4 Research & Development Expense
- 7.8 Cutera, Inc.
- 7.8.1 Company Overview
- 7.8.2 Financial Analysis
- 7.8.3 Segmental and Regional Analysis
- 7.8.4 Research & Development Expense
- 7.8.5 Recent strategies and developments:
- 7.8.5.1 Product Launches and Product Expansions:
- 7.9 Lumenis Ltd.
- 7.9.1 Company Overview
- 7.9.2 Recent strategies and developments:
- 7.9.2.1 Product Launches and Product Expansions:
- 7.10. Hologic, Inc.
- 7.10.1 Company Overview
- 7.10.2 Financial Analysis
- 7.10.3 Segmental and Regional Analysis
- 7.10.4 Research & Development Expense
- 7.10.5 Recent strategies and developments:
- 7.10.5.1 Acquisitions and Mergers:
- 7.10.5.2 Product Launches and Product Expansions:
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
